Efficacy News and Research

RSS

Researchers explore patient adherence, tolerability to class of Alzheimer's drugs

Researchers from the Indiana University Center for Aging Research and the Regenstrief Institute have performed the first study conducted in the United States under real-world conditions comparing patient adherence and tolerability to a class of drugs known as cholinesterase inhibitors.

11 Apr 2017

TSRI scientists find new way to make cell population resistant to HIV

Scientists at The Scripps Research Institute have found a way to tether HIV-fighting antibodies to immune cells, creating a cell population resistant to the virus.

11 Apr 2017

FDA grants approval for first drug to treat adults with tardive dyskinesia

The U.S. Food and Drug Administration today approved Ingrezza (valbenazine) capsules to treat adults with tardive dyskinesia. This is the first drug approved by the FDA for this condition.

11 Apr 2017

Researchers design first light-activated drug for treatment of pain

A team of the Institute of Neurosciences of the University of Barcelona has participated in the design of the first light-activated drug -the JF-NP-26, for the treatment of pain, according to a research with animal models published in the journal eLife.

11 Apr 2017

AAOS issues new guidelines for treatment of hip osteoarthritis

The American Academy of Orthopaedic Surgeons recently released a new clinical practice guideline on the treatment of osteoarthritis of the hip that strongly recommends the use of pre-surgical treatments to ease pain and improve mobility, including corticosteroid injections, physical therapy and non-narcotic medications.

11 Apr 2017

Careful counselling from clinicians may help alleviate anxiety in wAMD patients

Highly effective current treatments for vision loss need to be allied with careful counselling to ensure patients maintain good psychological health as well as good vision, new research recommends.

From The University of Manchester 11 Apr 2017

New study shows early signs of resistance among bed bugs to two commonly used insecticides

Pest management professionals battling the ongoing resurgence of bed bugs are wise to employ a well-rounded set of measures that reduces reliance on chemical control, as new research shows the early signs of resistance developing among bed bugs to two commonly used insecticides.

10 Apr 2017

People with burnout symptoms react faster to negative sounds of voice, study reveals

Approximately every fourth working aged Finn experiences symptoms of burnout that include exhaustion, cynicism and reduced professional efficacy and often also difficulties in concentration and memory.

10 Apr 2017

FDA grants approval for two drugs to treat hepatitis C virus in children

The U.S. Food and Drug Administration today approved supplemental applications for Sovaldi (sofosbuvir) and Harvoni (ledipasvir and sofosbuvir) to treat hepatitis C virus (HCV) in children ages 12 to 17. Harvoni and Sovaldi were previously approved to treat HCV in adults.

7 Apr 2017

Patients with inducible urticaria can benefit from treatment with asthma drug

Patients who develop itchy wheals in response to cold or friction benefit from treatment with omalizumab, a drug normally used to treat asthma.

7 Apr 2017

Researchers identify molecular switch that converts skin cells into blood vessel cells

Researchers from the University of Illinois at Chicago have identified a molecular switch that converts skin cells into cells that make up blood vessels, which could ultimately be used to repair damaged vessels in patients with heart disease or to engineer new vasculature in the lab.

7 Apr 2017

Comprehensive hospital standards released for improving quality of geriatric surgical care

The first comprehensive set of hospital-level surgical care standards for older adults has been released and published on the Annals of Surgery website in advance of print publication.

6 Apr 2017

Acelity launches V.A.C. VERAFLO CLEANSE CHOICE Dressing for complex wounds

C Acelity, a global advanced wound care company, today announced the global launch of the V.A.C. VERAFLO CLEANSE CHOICE Dressing, providing clinicians with a novel, adjunctive non-surgical option that may help clean large complex wounds when complete surgical debridement is not possible or appropriate.

6 Apr 2017

Efficacy News and Research

Researchers explore patient adherence, tolerability to class of Alzheimer's drugs

TSRI scientists find new way to make cell population resistant to HIV

FDA grants approval for first drug to treat adults with tardive dyskinesia

Researchers design first light-activated drug for treatment of pain

AAOS issues new guidelines for treatment of hip osteoarthritis

Careful counselling from clinicians may help alleviate anxiety in wAMD patients

New study shows early signs of resistance among bed bugs to two commonly used insecticides

People with burnout symptoms react faster to negative sounds of voice, study reveals

FDA grants approval for two drugs to treat hepatitis C virus in children

Patients with inducible urticaria can benefit from treatment with asthma drug

Researchers identify molecular switch that converts skin cells into blood vessel cells

Comprehensive hospital standards released for improving quality of geriatric surgical care

Acelity launches V.A.C. VERAFLO CLEANSE CHOICE Dressing for complex wounds

Researchers achieve new step towards treatment of myotubular myopathy using gene therapy

Oxytocin system may be key target for developing medications to treat opioid addiction

CBT program to promote alcohol abstinence among HIV-infected people could help save money

Low-dose penicillin in early life changes behaviour and balance of gut microbes

OSU scientists find way to fight solid tumors using new cancer-drug delivery system

Pitt scientists identify neural pathway that regulates coordinated hand movements

Researchers discover key to reveal secret of reversible aging recovery

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News